Hyperimmune Globulins Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

 Developed by experienced analysts, this report offers in-depth insights for understanding competition and customer behavior in the hyperimmune globulins industry.

 

 Hyperimmune Globulins Market Analysis & Forecast: 2025–2029
 The hyperimmune globulins market size has grown strongly in recent years. It will grow from $1.91 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increased government support, rise in healthcare expenditures.
 
 The hyperimmune globulins market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to the increasing prevalence of infectious diseases, growing awareness about the benefits of hyperimmune globulin injections, increasing demand for immunoglobulins, rising prevalence of alpha-1 antitrypsin deficiency, rising incidence of immune deficiencies. Major trends in the forecast period include technological advancements and innovation, investment in research and development, demand for passive immunity treatments, advancements in plasma-derived therapies, and technological advancements in manufacturing.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp
 
 What Are The Factors Driving The Hyperimmune Globulins Market?
 The increasing prevalence of infectious diseases is expected to propel the growth of the hyperimmune globulin market going forward. Infectious diseases are illnesses caused by harmful agents (pathogens) that get into your body, such as viruses, bacteria, fungi, and parasites. The increasing prevalence of infectious diseases can be attributed to factors such as antimicrobial resistance, climate change, and population growth. Hyperimmune globulins are utilized in infectious diseases to provide immediate passive immunity by delivering concentrated antibodies against specific pathogens, aiding in the prevention or treatment of diseases such as rabies, hepatitis B, or tetanus. For instance, in April 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, chronic hepatitis B cases in the US increased by approximately 17% from 14,229 cases in 2021 to 16,729 cases in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the hyperimmune globulin market.
 
 What Segments Are Covered In The Hyperimmune Globulins Market Report?
 The hyperimmune globulinsmarket covered in this report is segmented — 
 
 1) By Type: Hepatitis B Hyperimmune Globulin; Rabies Hyperimmune Globulin; Tetanus Hyperimmune Globulin; Cytomegalovirus (CMV) Hyperimmune Globulin; Varicella-Zoster Virus (VZV) Hyperimmune Globulin; Respiratory Syncytial Virus (RSV) Hyperimmune Globulin; Other Types
 2) By Route Of Administration: Intramuscular; Intravenous
 3) By Application: Government Institution; Private Sector; Other Applications
 
 Subsegments:
 1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin; Intravenous Hepatitis B Hyperimmune Globulin 
 2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human); Rabies Immune Globulin (Equine) 
 3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human); Tetanus Immune Globulin (Equine) 
 4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation; Cmv Immune Globulin For Neonatal Infection 
 5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis; Vzv Immune Globulin For Immunocompromised Patients 
 6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children; Rsv Immune Globulin For Adults With Respiratory Conditions 
 7) By Other Types: Diphtheria Hyperimmune Globulin; Botulism Hyperimmune Globulin; Other Specialized Hyperimmune Globulins
 
 
 
 
 Which Are The Major Players Operating In The Global Hyperimmune Globulins Market?
 Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.
 
 View the full hyperimmune globulins market report here:
 https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report
 
 Hyperimmune Globulins Market Regional Insights:
 North America was the largest region in the hyperimmune globulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company